Results for tag: "Fecal Incontinence Drug"

The Fecal Incontinence Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal disorders. Fecal incontinence drugs are used to treat the involuntary loss of bowel control, which can be caused by a variety of conditions, including neurological disorders, childbirth, and aging. These drugs can be used to reduce the frequency and severity of fecal incontinence episodes, as well as to improve the quality of life of those affected. Commonly used drugs include antidiarrheal medications, antispasmodics, and topical anesthetics. Some companies in the Fecal Incontinence Drug market include Allergan, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more